Search Results - H. Ohara
- Showing 1 - 7 results of 7
-
1
-
2
-
3
Real-world uptake and effectiveness of triplet versus doublet chemotherapy with bevacizumab in patients with metastatic colorectal cancer in the United States by W.J. Chapin, MD, MSCE, W.-T. Hwang, PhD, R. Mamtani, MD, MSCE, M.H. O’Hara, MD
Published in ESMO Gastrointestinal Oncology (2024-09-01)Get full text
Article -
4
671 Phase 1 trial of human chimeric antigen receptor modified T cells (huCART-meso) administered in combination with oncolytic virus VCN-01 in patients with pancreatic and ovarian... by Carl H June, Joseph A Fraietta, Gabriela Plesa, Amy Marshall, Mark H O’Hara, Janos L Tanyi, Elizabeth Hexner, Julie Jadlowsky, Matthew Ferrara, Olivia Farrelly, Adam Runkle, Anne Chew, Emily Dowd, Vanessa Gonzalez, Neil C Sheppard
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
5
765 NG-350A, a tumor-selective anti-CD40 agonist expressing therapeutic, gemcitabine/nab-paclitaxel and ipilimumab for untreated metastatic pancreatic adenocarcinoma: cohort C of t... by Robert H Vonderheide, Andrew H Ko, Danny Khalil, Oliver Rosen, Robert A Wolff, James Francis, Samantha Bucktrout, Christopher R Cabanski, Silvia Boffo, Zev A Wainberg, Samik Upadhaya, Eileen M O’Reilly, Mark H O’Hara, George Fisher, Jamie Arnott, Ana Rosa Saez-Ibanez, Jay Campbell, Ute Dugan, Jill O’Donnell-Tormey
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
6
Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors by Adham S. Bear, Rebecca B. Nadler, Mark H. O’Hara, Kelsey L. Stanton, Chong Xu, Robert J. Saporito, Andrew J. Rech, Miren L. Baroja, Tatiana Blanchard, Maxwell H. Elliott, Michael J. Ford, Richard Jones, Shivang Patel, Andrea Brennan, Zachary O’Neil, Daniel J. Powell Jr., Robert H. Vonderheide, Gerald P. Linette, Beatriz M. Carreno
Published in The Journal of Clinical Investigation (2024-11-01)Get full text
Article -
7
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma by Jacob E. Till, Lee McDaniel, Changgee Chang, Qi Long, Shannon M. Pfeiffer, Jaclyn P. Lyman, Lacey J. Padrón, Deena M. Maurer, Jia Xin Yu, Christine N. Spencer, Pier Federico Gherardini, Diane M. Da Silva, Theresa M. LaVallee, Charles Abbott, Richard O. Chen, Sean M. Boyle, Neha Bhagwat, Samuele Cannas, Hersh Sagreiya, Wenrui Li, Stephanie S. Yee, Aseel Abdalla, Zhuoyang Wang, Melinda Yin, Dominique Ballinger, Paul Wissel, Jennifer Eads, Thomas Karasic, Charles Schneider, Peter O’Dwyer, Ursina Teitelbaum, Kim A. Reiss, Osama E. Rahma, George A. Fisher, Andrew H. Ko, Zev A. Wainberg, Robert A. Wolff, Eileen M. O’Reilly, Mark H. O’Hara, Christopher R. Cabanski, Robert H. Vonderheide, Erica L. Carpenter
Published in Nature Communications (2024-07-01)Get full text
Article
